Vyvanse and Clozaril drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Vyvanse (lisdexamfetamine dimesylate) and Clozaril (clozapine). Common drug interactions include adverse reaction among females and weight increased among males.
The phase IV clinical study analyzes what interactions people have when they take Vyvanse and Clozaril. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Vyvanse?
Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,868 Vyvanse users. Check the latest studies of Vyvanse.
What is Clozaril?
Clozaril has active ingredients of clozapine. It is often used in schizophrenia. eHealthMe is studying from 65,127 Clozaril users. Check the latest studies of Clozaril.
11 people who take Vyvanse and Clozaril together, and have interactions are studied.

What are the common drug interactions of Vyvanse and Clozaril, by gender? *:
female:
- Adverse reaction
- Depressed mood
- Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
- Panic reaction
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
male:
- Weight increased
- Eating disorder
- Negative thoughts
- Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
- Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
- Sleep disorder
- Tardive dyskinesia (a disorder that involves involuntary movements)
- White blood cell count increased
- Psychotic disorder
What are the common drug interactions of Vyvanse and Clozaril, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
- Weight increased
- White blood cell count increased
- Psychotic disorder
- Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
- Lipids increased (excess lipid in body)
- Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
20-29:
- Aggression
- Eating disorder
- Hallucination (an experience involving the perception of something not present)
- Sleep disorder
- Weight increased
30-39:
- Adverse reaction
40-49:
n/a
50-59:
n/a
60+:
n/a
What are the existing conditions these people have? *
- Stress And Anxiety: 3 people, 27.27%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 18.18%
- Schizoaffective Disorder Bipolar Type (mental illness featuring schizophrenia and a mood disorder with mania): 2 people, 18.18%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 18.18%
- Mood Swings (an extreme or rapid change in mood): 2 people, 18.18%
- Depression: 2 people, 18.18%
- Tardive Dyskinesia (a disorder that involves involuntary movements): 1 person, 9.09%
- Psychotic Disorder: 1 person, 9.09%
- Metabolic Syndrome (a combination of the medical disorders that, when occurring together, increase the risk of developing cardiovascular disease): 1 person, 9.09%
- Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Vyvanse and Clozaril?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Vyvanse and Clozaril:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vyvanse:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Clozaril:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vyvanse and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Clozaril and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Grover S, Sahoo S, "Clozapine induced akathisia: A case report and review of the evidence", Indian journal of pharmacology, 2015 Jan .
- Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Grover S, Sahoo S, "Clozapine induced akathisia: A case report and review of the evidence", Indian journal of pharmacology, 2015 Jan .
- Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on lisdexamfetamine dimesylate and clozapine (the active ingredients of Vyvanse and Clozaril, respectively), and Vyvanse and Clozaril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Arava cause Arthropathy? - a second ago
- Could Pepcid cause Drug Administration Error? - 3 seconds ago
- Could Eliquis cause Leukopenia? - 5 seconds ago
- Could Acetylcysteine cause Gastrointestinal Motility Disorder? - 8 seconds ago
- Drug interactions of Profen and Topicort - 11 seconds ago
- Could Glucotrol cause Metastases To Adrenals? - 11 seconds ago
- Could Pomalyst cause Weight Decreased? - 16 seconds ago
- Could Irbesartan cause Protein Total Increased? - 17 seconds ago
- Could Loraz cause Hepatic Cirrhosis? - 19 seconds ago
- Could Carboplatin cause Thrombosis? - 21 seconds ago